todd unger

AMA Update 151: Paxlovid side effects, treatment timelines and more with John Farley, MD, MPH

AMA CXO Todd Unger discusses what physicians and patients need to know about Paxlovid with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA.

For more information on Paxlovid from the FDA, visit: https://www.fda.gov/drugs/news-events-human-drugs/fda-updates-paxlovid-health-care-providers

Read More

AMA Update 129: New CDC guidelines and tracking COVID-19 risk in your area with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering new data from CDC studies, understanding community risk and finding your local COVID-19 Community Level, as well as positive long-lasting effects of COVID booster shots.

Access the Centers for Disease Control and Prevention’s «COVID-19 by County» tracker here: https://www.cdc.gov/coronavirus/2019-ncov/your-health/covid-by-county.html

Read More

AMA Update 119: Andrea Garcia, JD, MPH, covers new CDC study findings, full FDA approval for Moderna vaccine & Novavax authorization request

AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Including the new “stealth Omicron” variant, as well as data from the latest CDC study showing third doses/booster shots bolster COVID defenses for both the immunocompromised and people with stronger immune systems. Also recapping AMA’s joint statement with the American Hospital Association (AHA) and the American Nurses Association (ANA) on blood shortages.

Read More

AMA Update 118: AMA President Gerald Harmon, MD, discusses physicians’ vital role in a «pandemic of mistrust»

AMA CXO Todd Unger talks with AMA President Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., about the important role physicians can play at this pivotal time in the pandemic and the support they need to do so.

Read More

AMA Update 117: Peter Hotez, MD, PhD, on his new COVID vaccine

AMA CXO Todd Unger talks with Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children’s Hospital Center for Vaccine Development in Houston, to learn about his new COVID vaccine and how it fits into our global pandemic response.

Read More

AMA Update 114: Jonathan Ripp, MD, MPH, on clinician well-being in Omicron’s wake

AMA CXO Todd Unger discusses clinician well-being in the COVID “new normal» with Jonathan Ripp, MD, MPH, dean for well-being and resilience at the Icahn School of Medicine at Mount Sinai and chief wellness officer at Mount Sinai Health System.

Read More

AMA Update 113: Leana Wen, MD, MSc, assesses the COVID endgame post-omicron surge

AMA CXO Todd Unger talks with Leana Wen, MD, MSc, public health professor at George Washington University, a columnist with the Washington Post, and a CNN medical analyst, about how physician communication and leadership can clear up COVID confusion for individual patients—as well as the nation.

Read More

AMA Update 112: Andrea Garcia, JD, MPH, discusses what to expect with the Omicron surge

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering developments in COVID hot spots across the nation, the CDC’s clarified stance on masks, and Dr. Fauci’s «five phases of the pandemic.»

Read More

AMA Update 111: Leonard Nelson, JD, on how vaccine mandate rulings impact physicians

AMA CXO Todd Unger talks with Leonard Nelson, JD, the AMA’s senior assistant general counsel, about the recent Supreme Court decisions on vaccine mandates and their long-term implications for physicians.

Read More